Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients
- First Posted Date
- 2021-02-26
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Instituto Oncológico Dr Rosell
- Target Recruit Count
- 32
- Registration Number
- NCT04772235
- Locations
- 🇪🇸
Hospital Regional Universitario de Málaga, Málaga, Andalucia, Spain
🇪🇸Hospital Son Espases, Palma, Baleares, Spain
🇪🇸Quiron Dexeus, Barcelona, Cataluña, Spain
Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge
- Conditions
- Covid19Pulmonary Fibrosis
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2020-09-24
- Lead Sponsor
- Instituto Oncológico Dr Rosell
- Target Recruit Count
- 40
- Registration Number
- NCT04537130
- Locations
- 🇪🇸
Hospital El Pilar, Barcelona, Spain
Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer
- Conditions
- Extensive-stage Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2020-07-27
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Instituto Oncológico Dr Rosell
- Target Recruit Count
- 20
- Registration Number
- NCT04487756
- Locations
- 🇪🇸
ICO Badalona, Badalona, Barcelona, Spain
🇪🇸Quirón Dexeus, Barcelona, Spain
🇪🇸Hospital Clínic Barcelona, Barcelona, Spain
E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2022-06-30
- Lead Sponsor
- Instituto Oncológico Dr Rosell
- Target Recruit Count
- 23
- Registration Number
- NCT03623750
- Locations
- 🇪🇸
Hospital Universitario Insular de Gran Canaria, Palmas de Gran Canaria, Canarias, Spain
🇪🇸Instituto Oncológico Dr. Rosell, Barcelona, Spain
🇪🇸Hospital Clínic Barcelona, Barcelona, Spain